These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33962357)

  • 1. Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.
    Aghevlian S; Wu B; Raie MN; Tumbale SK; Kare AJ; Seo JW; Ferrara KW
    Nucl Med Biol; 2021; 98-99():8-17. PubMed ID: 33962357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
    Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [
    Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM
    Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
    Lee JH; Kim H; Yao Z; Lee SJ; Szajek LP; Grasso L; Pastan I; Paik CH
    Nucl Med Biol; 2015 Nov; 42(11):880-6. PubMed ID: 26307499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and preclinical studies of
    Lam K; Chan C; Reilly RM
    MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
    Dearling JL; Voss SD; Dunning P; Snay E; Fahey F; Smith SV; Huston JS; Meares CF; Treves ST; Packard AB
    Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-PET of tissue factor in pancreatic cancer.
    Hong H; Zhang Y; Nayak TR; Engle JW; Wong HC; Liu B; Barnhart TE; Cai W
    J Nucl Med; 2012 Nov; 53(11):1748-54. PubMed ID: 22988057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of renal clearance of [
    Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
    Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W
    PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
    Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
    Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
    Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.